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In hypertension, an increase m pressure-workload fosters adaptive changes m the endothehum, the vascular smooth muscle, and the extracellular matrix of vessels and the heart However, m many patients, the adaptive changes to hypertenslon, which occur m the kidney, heart, and vessels, are m fact maladaptlve because they are harbingers of renal failure, cardiac failure, and coronary artery &sease 5 Obviously, there 1s a need for ways to identify those patients who are at higher nsk for development of end-organ disease In this context, recent studies have shown that a deletion polymorphism of the ACE gene 1s associated with target-organ damage m hypertension Specifically, the D allele of the ACE gene 1s associated with mlcroalbummuna, LVH, and coronary artery disease as well as the renal comphcatlons of insulin-dependent diabetes ',* The endothelmm plays a crucial role m the regulation of vascular tone and vascular remodeling R'" NO synthesized by a constltutlve endothehal NOS 1s an endogenous vasodllator and antlthrombogemc agent, which inhibits vascular smooth muscle and mesanglal cell growth and therefore may partlclpate m vascular as well as glomerular remodeling m response to hypertensive inJury '","
The assoclatlon between increased actlvlty of the local tissue renm-angotensm system and vascular pathophyslology has been well demonstrated '" NO appears to be the major endogenous antagonist of the vascular actions of Ang II and, therefore, a balance between Ang II and NO appears pivotal for the maintenance of vascular homeostasls'" Gwen the close assoclatlon between abnormal renal parameters and cardiovascular morbldlty/mortahty and the growing evidence for NO m vascular physiology and pathology, recent studies have focused on the role of NO m hypertensive renal disease as well as its relationship with concomitant Injury affecting the left ventricle and large vessels such as the aorta "-M The glomerulus 1s made up of the glomerular basement membrane, the eplthehal cells outhmng the glomerular basement membrane m the urinary space, and the mesangmm forming the glomerular centrolobular area I5 " The glomerular basement membrane reflects over the mesangmm between the capillary loops but 1s absent at the point of contact between the glomerular endothehal cells and the mesangal cells A barner between clrculatmg glomerular blood and the mesangmm 1s thus formed by the single layer of fenestrated endothehum Passage of plasma carrying large as well as small molecules is possible through the mesangal area because of the large size of the glomerular endothehal fenestrae The products synthesized by the endothehal and mesangal cells are able to reach each other m high concentrations because of their close proximity I5 "
Mesangal cells contam actm-myosm filaments and change their contractile state m response to vasoactlve substances, much as vascular smooth muscle cells do I516 Agents such as Ang II, elcosanolds, ET-l, and NO synthesized and released locally can act on these cells m autocnne and/or paracnne fashion The antagonistic interaction of locally synthesized Ang II and NO 1s important m the regulation of renal physiology and renal pathology In the glomerulus, modulation of the glomerular mlcroclrculatlon 1s possible under phynologcal and pathologcal con&tlons when these vasoactlve agents act on the mesangmm or the afferent and efferent artenole, or both "-19 The responses of glomerular cells to mJury and resulting architectural changes of the glomerulus such as mesanglal hypertrophy, mesangal hyperplasla, and increased mesangal cell matnx production are often due to the added effects of hemodynarmc (glomerular hypertension) and nonhemodynamlc actions of these vasoactlve agents, much as occurs m systemic vascular beds " Ang II has been found to control growth factors such as platelet-derived growth factor and transformmg growth factor p, which have been lmphcated m the pathologcal remodeling of the glomerulus m response to qury 2~1~2' However, NO not only antagonizes the effects of Ang II on artenolar tone and mesanpal contraction but mhlblts the response of mesangal cells to growth-stlmulatmg signals dnven by Ang II that lead to mesanglal cell hypertrophy and/or hyperplasla as well as to increased matnx production 2"-22
A dose-dependent increase m blood pressure and renovascular resistance occurs m response to systemic admmlstratlon of NO synthesis mhlbltors These changes are accompanied by a significant reduction m renal plasma flow and a moderate decrease m glomerular filtration rate Is23 NO mhlbmon also leads to an increase m afferent artenolar resistance'" and to a decrease m the ultrafiltration coefflclent, the latter probably being mediated by mesanglal cell contraction " In ad&on, macula densa NO appears to control glomerular hemodynam-KS by way of tubuloglomerular feedback mechanisms 24 Renal sodium excretion may also be affected by the direct action of NO on the tubules and its abdlty to modify medullary blood flow and interstitial pressure 25 Selective mhlbmon of NO synthesis m the renal medullary mterstmum decreases papillary blood flow and dlmmlshes unnary sodium excretion but does not alter glomerular filtration rate or systemic blood pressure 25
Interaction
Between AI1 and NO Increased actions of Ang II or NO may be due to an actual increase m the local concentration of the mdlvldual agent and/or to a conconutant decrease m the concentration of the other 26 Moreover, chronic NO synthesis mhlbmon Induces glomerular and tubulomterstltlal mJuryyIJ as well as coronary vascular remodeling and LVH that 1s accompanied by increased ACE expression and activity 27 This would suggest that decreased vascular NO bloactlvlty due to endothehal dysfunction as seen m hypertension may promote vascular hypertrophy due to a combined deficit of NO and local excess of Ang II Indeed, experimentally, m vlvo transfectlon of excess ACE to artenal segments results m localized vascular hypertrophy mediated by Ang II *' Ang II has been reported to activate NADH/NADPH oxldase m vascular smooth muscle cells2' and more recently m mesangal cells,'" leading to the cells' protracted synthesis of 02-02-has great afflmty for NO, causing mteractlon between the two and resulting m either NO mactlvatlon or the production of toxic peroxymtnte 3' Furthermore, m the glomerulus as m the vasculature m general, decreased NO bloactwlty not only reduces the ability of NO to counteract Ang II actions on vascular tone but also dtmmlshes the homeostatlc role of NO m preventing vascular thrombosis, leukocyte adhesion to endothehum, and Ang II-dnven mesangal cell hypertrophy/hyperplasla and production of extracellular matnx "
ET-l, a powerful vasoconstnctor, 1s capable of reducmg renal blood flow and glomerular filtration rate by acting on preglomerular resistances and mducmg mesanglal cell contraction 32 The interaction between NO and ET-l appears to be more Important under pathologlcal than under physlologcal condmons In addition, ET-1 synthesis 1s upregulated by Ang II33 and downregulated by NO 3J ET-l may thus play its role late rather than early m renal pathophyslologlcal processes In that Its Importance may build as the renal bloactnq of NO decreases
Hypertensive
Renal Injury
Capillary pressures and flows m the glomerulus are regulated by independent changes m resistance of the afferent and efferent arterioles and coordmated by the concomitant contractlon (or relaxation) of the mesangmm '7-'y35 Under normal physlolog& condltlons, an increase m systemic blood pressure 1s accompanied by an increase m preglomerular resistances (autoregulation), permlttmg the coexistence of systemic hypertension and glomerular normotension.
Glomerular injury has been shown to occur m cxpcrnncntal models m which a deficient preglomerular resistance results m elevated glomerular mtracaplllary pressures (glomerular hypertension); this scenarlo also occurs m the presence of diabetes,'" m surgical ablation of renal mass,jh and m hypertensive DS rats.?'
Comparative studies m genetic models of hypertension, such ac SHR and DS ratv and their normotenclve counterparts, have been particularly lllummating in providing insight into the relationship between hypertension, endothelial function, and end-organ mJury'*~" "-") (Flgr 1 and 2). Snmlar to the sltuatlon in some populations of humans, hypertension develops in DS rats given diets high m salt but not those given low or normal dietary salt.'"."' SHR, however, develop hypertension without high levels of dietary salt. We have previously shown that glomerular hypertension and glomerular injury develop m DS rats but not SHR at similar levels of systemic hypertension?' Indeed, preglomerular resistances are regulated poorly m DS rats, while m SHR, appropriate autoregulation and effective increase in preglomerular resistances prevent glomerular hypertension." Dahl rats were from the Brookhaven strain.
The endothelium and the mesangium are the most vulnerable glomerular structures in glomerular hypertension. The endothelial dysfunction and pathological remodeling that occur in the kidney as well as in other vascular beds as a consequence of increased blood pressure may not be entirely explained by the increased hemodynamic workload imposed by hypertension, however, except perhaps when it is very severe,12-14,37
NOS and Hypertensive Injury
In vitro studies have demonstrated that hemodynamic forces such as shear stress"' and cyclic straindi increase vascular NO production by increasing endothelial NOS expression, NOS protein, and NOS activity. Our laboratory has used age-matched SHR and DS rats with hypertension of similar severity and duration to investigate the relationship between hypertension and vascular NOS activity, "-M Endothelium-dependent relaxation mediated by NO is normal in hypertensive SHR, whereas it is dramatically impaired in DS rats. Aortic calcium-dependent NOS activity measured by the conversion
was increased 106% in SHR but reduced by 73% in DS rats compared with their normotensive counterparts."." These results explain why endothelium-dependent relaxation mediated by NO is impaired in DS rats but not in SHR. Endothelium-dependent relaxation was also impaired in renal and mesenteric vessels of hypertensive DS rats."-'" Increased NOS activity in SHR would thus suggest that these rats are able to upregulate and maintain high levels of vascular NOS in response to hypertension."-"' These findings also suggest that, by contrast, the endothelium of DS rats not only fails to increase NOS activity but in fact decreases it in response to hypertension.'2m'" Hence, heightened vascular NOS activity probably represents "normal physiological" adaptation to the increased hemodynamic forces (ie, cyclic strain) in hypertensive states. On a similar note, serum levels of NOJNO?, which are stable metabolites of NO, increase in SpragueDawley rats rendered hypertensive by placement of a clip in one of the renal arteries.*" High dietary salt did not foster hypertension, cardiac and aortic hypertrophy, or renal injury in Dahl salt-resistant rats.1'-'4 Concomitantly, in DS rats, antihypertensive therapy consisting of an ACE inhibitor and a diuretic prevented hypertension, the fall in NOS and abnormal aortic endotheliurn-dependent relaxation, LVH, and renal injury.'" This further supports the notion that in DS rats, end-organ injury and the fall in NOS activity are a consequence and not a cause of hypertension. If these observations made in the genetic rat models of hypertension apply to humans, they may provide important insights into the pathogenesis and therapy of cardiovascular disease.
Link Between NOS Activity and Renal, Vascular, and Cardiac Injury in Experimental Hypertension
Findings in comparative studies of SHR and hypertensive DS rats suggesting a link between NOS activity, vascular remodeling, and end-organ injury are particularly striking. In SHR, aortic hypertrophy did not occur and LVH increased only Nitric Oxide and Hypertensive Injury 15% " In hypertensive DS rats on the other hand, the aorta and left ventricle hypertrophled 36% and 88%, respectively, and there was m fact a significant negative correlation between NOS activity and aortlc and left ventricular hypertrophy "-" In the kidney, increased NOS activity m SHR was accompanied by mmlmal glomemlar and tubulomterstltlal &sease as well as mmlmal urinary protein excretion In hypertensive DS rats, however, renal NOS activity fell, and severe glomerular qury, heavy protemuna, and marked tubulomterstltlal disease occurredI (Figs 1 and 2) In conclusion, our experimental findings and those of others strongly suggest that m hypertension, NOS actlvlty 1s linked with end-organ disease and that impaired NOS actlvlty may be more commonly seen m salt-sensitive models of hypertens1on 12-14 Studies m humans have suggested a smular scenario that salt-sensitive hypertensive patients are more prone to development of end-organ disease, particularly LVH and renal disease 40*4' Further, clinical studies m humans have suggested that impaired endothehum-dependent relaxations mediated by NO may not be a universal fin&g m hypertension 4546 The prevalence of LVH, renal failure, and stroke, which are major causes of morbldlty and mortality, vanes m different populations of hypertensive patients 2 5 47*48 In recent human studies, genetic polymorphism m the remn-anglotensm system has been associated with cardiovascular and renal disease m hypertension and m diabetes " Inspired by these associations and the findings described, it 1s temptmg to speculate that vascular NOS activity m response to hypertension 1s genetically determined and that the heterogeneity may at least partially explain the different rates of occurrence of end-organ disease m humans with hypertension of slmllar seventy 2 ' 47 48 
